IFP Advisors’s Gyre Therapeutics GYRE Stock Holding History

IFP Advisors’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7	Buy	+1	New	+$7	﹤0.01%	5185
2025 Q3	–	Sell	-1	Closed	-$7	–	4876
2025 Q2	$7	Sell	1 -1	-50%	-$9	﹤0.01%	4881
2025 Q1	$15	Hold	2	–	–	﹤0.01%	4200
2024 Q4	$24	Buy	+2	New	+$26	﹤0.01%	4424

Other funds holding GYRE

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

IFP Advisors's GYRE Position: Q3 2026 in Review

IFP Advisors opened a new position in Gyre Therapeutics (GYRE) in Q3 2026: 1 share worth $7. The stake represents ﹤0.01% of the portfolio and ranks #5185 among its holdings. This is a return to the name: IFP Advisors previously reported a position in GYRE as recently as Q2 2025.

IFP Advisors first reported a position in GYRE in Q4 2024 and has held it in 4 quarters since. The position peaked at $24 in Q4 2024. 7 funds tracked by Wall St. Rank hold GYRE as of Q3 2026.

IFP Advisors held 1 share of Gyre Therapeutics worth $7 as of Q3 2026.
Gyre Therapeutics was a new IFP Advisors position in Q3 2026.
Gyre Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5185 holding.
IFP Advisors first reported a position in Gyre Therapeutics in Q4 2024 and has held it in 4 quarters since.
IFP Advisors's Gyre Therapeutics position peaked at $24 in Q4 2024.
7 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.